Kite Pharma (KITE) – Hot FDA News
-
FDA panel backs Novartis' pioneering new cancer gene therapy
-
Kite Pharma (KITE) Reports Positive Topline Data on Axicabtagene Ciloleucel from First Pivotal CAR-T Trial in Patients with Aggressive NHL
-
-
-
Back to KITE Stock Lookup